Vimarsana
Biggest News Aggregation in the World

Cardiovascular Interventions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cardiovascular Interventions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cardiovascular Interventions Today - Breaking & Trending Today

Heat Exposure & Heart Stress; 2-Hour POC Troponin Assay; Colchicine After Stroke? - Vimarsana News

Heat Exposure & Heart Stress; 2-Hour POC Troponin Assay; Colchicine After Stroke?

Recent developments of interest in cardiovascular medicine

Fish Oil Benefits or Harms; Statins at Age 85+; Doc's Hunger Strike for Bed Space - Vimarsana News

Fish Oil Benefits or Harms; Statins at Age 85+; Doc's Hunger Strike for Bed Space

Recent developments of interest in cardiovascular medicine

Gene Therapy Allowing Heart to Grow New Blood Vessels Supported by Early Data - Vimarsana News

Gene Therapy Allowing Heart to Grow New Blood Vessels Supported by Early Data

Researchers are eyeing catheter-based delivery for people with refractory angina

Research: The Foundations of Advanced Heart Care - Vimarsana News

Research: The Foundations of Advanced Heart Care

ALBANY – The latest therapies and leading-edge surgical techniques used by Albany Med Health System’s cardiologists and cardiothoracic surgeons were all made possible by previous clinical, translational, and basic science research. Within the System, our scientists and clinicians are also advancing the understanding of heart diseases and related conditions. Contributions to Diagnosis and Treatment Studies The latest therapies and leading-edge surgical techniques used by Albany Med Health System’s cardiologists and cardiothoracic surgeons were all made possible by previous clinical, trans...

Impella CP Improves Survival in STEMI, Cardiogenic Shock - Vimarsana News

Impella CP Improves Survival in STEMI, Cardiogenic Shock

Use of a microaxial flow pump led to a lower risk of death in patients with STEMI-related cardiogenic shock in the DanGer Shock trial, although with more adverse events.